par Niviere, Thomas 
;Sculier, Jean-Paul ;Meert, Anne-Pascale ;Berghmans, Thierry
Référence Revue des maladies respiratoires, 35, 1, page (55-61)
Publication Publié, 2018-01
;Sculier, Jean-Paul ;Meert, Anne-Pascale ;Berghmans, Thierry Référence Revue des maladies respiratoires, 35, 1, page (55-61)
Publication Publié, 2018-01
Article révisé par les pairs
| Résumé : | Introduction: Brain metastases are a common complication of bronchial carcinoma (BC). There is no consensus as to the need to undertake a systematic search for these lesions during the initial assessment. The aim of this study was to evaluate the contribution of brain imaging in the initial evaluation of patients with CB. Methods: We undertook a retrospective analysis of patients treated in the Thoracic Oncology Clinic at the Institute Jules-Bordet between 01/09/2008 and 31/08/2013, who were treatment-naïve and were having a full diagnostic work-up including brain imaging. Results: Four hundred and sixty-three patients consecutively diagnosed with BC were included. Brain magnetic resonance imaging and/or CT-scan showed brain metastases in 101 patients (21.8%), of whom 67 had no symptoms suggestive of brain metastatic disease. The addition of a brain imaging into the work-up procedure resulted in a stage migration for 30 patients (6.5%), mainly otherwise staged IIIA (n = 10) or IIIB (n = 14) without brain imaging. Conclusion: The addition of brain imaging in the initial assessment of bronchial carcinoma allows the identification of brain metastases in one case among 5, of which 2/3 are asymptomatic. This leads to a change in staging, primarily for disease otherwise considered to be stage III. |
